MYB is a novel regulator of pancreatic tumour growth and metastasis

Sanjeev K. Srivastava(USA Mitchell Cancer Institute), Ajay P. Singh(USA Mitchell Cancer Institute)
British Journal of Cancer
December 1, 2015
10.1038/bjc.2015.400
Cited by 51

Related Papers

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
|British Journal of Cancer|2017|257
CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
|British Journal of Cancer|2010|221
An Undesired Effect of Chemotherapy
|Journal of Biological Chemistry|2013|164
Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells
|PLoS ONE|2011|132
CXCL12/CXCR4 Protein Signaling Axis Induces Sonic Hedgehog Expression in Pancreatic Cancer Cells via Extracellular Regulated Kinase- and Akt Kinase-mediated Activation of Nuclear Factor κB
|Journal of Biological Chemistry|2012|121